ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Insulin delivery
Pediatr Diabetes
.
2022 Dec;23(8):1406-1431.
doi: 10.1111/pedi.13421.
Epub 2022 Dec 5.
Authors
Jennifer L Sherr
1
,
Melissa Schoelwer
2
,
Tiago Jeronimo Dos Santos
3
,
Leenatha Reddy
4
,
Torben Biester
5
,
Alfonso Galderisi
6
,
Jacobus Cornelius van Dyk
7
,
Marisa E Hilliard
8
,
Cari Berget
9
,
Linda A DiMeglio
10
Affiliations
1
Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
2
Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia, USA.
3
Pediatrics Unit, Vithas Almería, Instituto Hispalense de Pediatría, Almería, Andalusia, Spain.
4
Department of Pediatrics Endocrinology, Rainbow Children's Hospital, Hyderabad, India.
5
AUF DER BULT, Hospital for Children and Adolescents, Hannover, Germany.
6
Department of Woman and Child's Health, University of Padova, Padova, Italy.
7
Department of Pediatrics, Life Groenkloof Hospital, Pretoria, South Africa.
8
Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
9
Barbara Davis Center, University of Colorado School of Medicine, Aurora, Colorado, USA.
10
Department of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
PMID:
36468192
DOI:
10.1111/pedi.13421
No abstract available
Keywords:
automated insulin delivery; connected pens; diabetes technology; insulin pumps.
Publication types
Review
MeSH terms
Diabetes Mellitus, Type 1*
Humans
Hypoglycemic Agents
Insulin*
Technology
Substances
Insulin
Hypoglycemic Agents